A 6-year surveillance of antimicrobial resistance patterns of Acinetobacter baumannii bacteremia isolates from a tertiary care hospital in Saudi Arabia during 2005-2010.
作者信息
Gowda Krishnappa Lakshmana, Marie Mohammed A M, Al-Sheikh Yazeed A, John James, Gopalkrishnan Sangeetha, Shashidhar Pradeep Chikkabidare, Dabwan Khaled Homoud M
机构信息
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia;
出版信息
Libyan J Med. 2014 Apr 3;9(1):24039. doi: 10.3402/ljm.v9.24039. eCollection 2014.
Abstract
摘要
相似文献
1
A 6-year surveillance of antimicrobial resistance patterns of Acinetobacter baumannii bacteremia isolates from a tertiary care hospital in Saudi Arabia during 2005-2010.
Libyan J Med. 2014 Apr 3;9(1):24039. doi: 10.3402/ljm.v9.24039. eCollection 2014.
2
Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia.
New Microbiol. 2014 Jan;37(1):65-73. Epub 2014 Jan 15.
3
Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
J Med Microbiol. 2012 Jan;61(Pt 1):71-79. doi: 10.1099/jmm.0.033852-0. Epub 2011 Aug 18.
4
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.
5
Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
PLoS One. 2015 Jun 17;10(6):e0130701. doi: 10.1371/journal.pone.0130701. eCollection 2015.
6
Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
J Microbiol Immunol Infect. 2015 Dec;48(6):588-96. doi: 10.1016/j.jmii.2015.03.003. Epub 2015 May 14.
7
Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.
Am J Ther. 2019 Nov/Dec;26(6):e778-e780. doi: 10.1097/MJT.0000000000000949.
8
Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
Scand J Infect Dis. 2006;38(5):335-40. doi: 10.1080/00365540500488907.
9
Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
Scand J Infect Dis. 2010 Oct;42(10):741-6. doi: 10.3109/00365548.2010.489568.
10
Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Ann Clin Microbiol Antimicrob. 2019 Jan 3;18(1):1. doi: 10.1186/s12941-018-0301-x.
引用本文的文献
1
Acinetobacter baumannii: A multidrug-resistant pathogen, has emerged in Saudi Arabia.
Saudi Med J. 2023 Aug;44(8):732-744. doi: 10.15537/smj.2023.44.8.20230194.
2
Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Ann Clin Microbiol Antimicrob. 2019 Jan 3;18(1):1. doi: 10.1186/s12941-018-0301-x.
3
Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.
Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1073-1081. doi: 10.1007/s10096-016-2895-2. Epub 2017 Jan 18.
4
A stepwise introduction of a successful antimicrobial stewardship program. Experience from a tertiary care university hospital in Western, Saudi Arabia.
Saudi Med J. 2016 Dec;37(12):1350-1358. doi: 10.15537/smj.2016.12.15739.
5
High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia.
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1759-1766. doi: 10.1007/s10096-016-2723-8. Epub 2016 Aug 16.
6
A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.
Bosn J Basic Med Sci. 2015 Oct 14;15(4):24-9. doi: 10.17305/bjbms.2015.526.
本文引用的文献
1
Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes.
Clin Infect Dis. 2010 Jun 15;50(12):1611-6. doi: 10.1086/652759.
2
Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care.
Crit Care Nurse. 2008 Feb;28(1):15-25; quiz 26.
3
Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide.
Infect Control Hosp Epidemiol. 2006 Jul;27(7):645-6. doi: 10.1086/505900. Epub 2006 Jun 23.
4
The epidemiology and control of Acinetobacter baumannii in health care facilities.
Clin Infect Dis. 2006 Mar 1;42(5):692-9. doi: 10.1086/500202. Epub 2006 Jan 26.
5
Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition.
J Hosp Infect. 1997 Oct;37(2):113-23. doi: 10.1016/s0195-6701(97)90181-x.
Zotero 插件